Severe Aplastic Anaemia Working Party (SAAWP)
COVID-19
Study type:
Study number:
84090085
Type of treatment:
Diseases:
Bone marrow failure
Short title:
SARS-CoV-2 vaccination in non-transplanted AA/PNH patients
Primary objective:
To study the impact of SARS-CoV-2 vaccination for non-transplanted AA and/or PNH patients
Key inclusion criteria:
Patients are eligible if:
- they have been diagnosed with AA and/or PNH, irrespective of vaccination status;
- they have received the first SARS-CoV-2 vaccination before 01-08-2021;
- they are under active follow-up (to allow CRF completion);
- they have not yet undergone a bone marrow transplant.
Patients are not eligible if:
- they have undergone bone marrow transplant;
- they are paediatric patients (due to vaccinations not being undertaken in this population at the start of this study, this may be revisited at a later date)
- they have been diagnosed with AA and/or PNH, irrespective of vaccination status;
- they have received the first SARS-CoV-2 vaccination before 01-08-2021;
- they are under active follow-up (to allow CRF completion);
- they have not yet undergone a bone marrow transplant.
Patients are not eligible if:
- they have undergone bone marrow transplant;
- they are paediatric patients (due to vaccinations not being undertaken in this population at the start of this study, this may be revisited at a later date)
Country:
Principal investigator:
Morag Griffin
EBMT Study coordinator:
Inge Verheggen
Study coordinator email:
saawpebmt@lumc.nl